TY - JOUR
T1 - BMY-28100 in internal infections
AU - Kawabe, Hiroshi
AU - Matsuoka, Yasuo
AU - Irimajiri, Shoichiro
PY - 1989/1/1
Y1 - 1989/1/1
N2 - A new antibiotic, BMY-28100, was administered for 4-17 days at a daily dose of 750 or 1500mg to 22 patients (pneumonia 4 cases, acute bronchitis 4, acute tonsillitis 3, acute pharyngitis 4, acute pyelonephritis 5, and acute cystitis 2). The results were effective in 16 cases, and the overall efficacy rate was 72.7%. A side effect was observed in 1 patient (eruption), and abnormal laboratory findings were observed in 4 (3 cases of GPT and 1 of GOT, GPT elevation).
AB - A new antibiotic, BMY-28100, was administered for 4-17 days at a daily dose of 750 or 1500mg to 22 patients (pneumonia 4 cases, acute bronchitis 4, acute tonsillitis 3, acute pharyngitis 4, acute pyelonephritis 5, and acute cystitis 2). The results were effective in 16 cases, and the overall efficacy rate was 72.7%. A side effect was observed in 1 patient (eruption), and abnormal laboratory findings were observed in 4 (3 cases of GPT and 1 of GOT, GPT elevation).
UR - http://www.scopus.com/inward/record.url?scp=0024930850&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024930850&partnerID=8YFLogxK
U2 - 10.11250/chemotherapy1953.37.Supplement3_300
DO - 10.11250/chemotherapy1953.37.Supplement3_300
M3 - Article
AN - SCOPUS:0024930850
VL - 37
SP - 300
EP - 304
JO - CHEMOTHERAPY
JF - CHEMOTHERAPY
SN - 0009-3165
ER -
